Outpatient treatment for opioid use disorder and related infections
DAT- Integrated Outpatient Treatment of Opioid Use Disorder and Injection-Related Infections
This study is looking at whether people with opioid use disorder and serious infections can safely get their antibiotic treatment at home instead of needing to stay in the hospital, making care easier and more affordable for them.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Kentucky NIH-funded |
| Lab location | 1 site (Lexington, United States) |
| Project ID | NIH-10673063 on NIH RePORTER |
What this research studies
This research investigates the effectiveness of outpatient treatment for individuals with opioid use disorder (OUD) who also suffer from severe injection-related infections. It aims to challenge the common assumption that these patients must remain hospitalized to complete their antibiotic treatments. By utilizing outpatient parenteral antibiotic therapy (OPAT), the study seeks to provide a more cost-effective and patient-centered approach to care. The research will explore innovative clinical models that facilitate safe and effective outpatient management of these patients.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with opioid use disorder who are experiencing severe injection-related infections and are medically stable enough to receive outpatient care.
Not a fit: Patients who are not diagnosed with opioid use disorder or those who are not experiencing injection-related infections may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved treatment options for patients with opioid use disorder and related infections, reducing hospital stays and associated costs.
How similar studies have performed: Previous research has shown that outpatient parenteral antibiotic therapy can be effective for other patient populations, suggesting potential success for this approach in treating patients with opioid use disorder.
Where this research is happening
Lexington, United States
- University of Kentucky — Lexington, United States (Active)
Researchers
- Principal investigator: Fanucchi, Laura — University of Kentucky
- Study coordinator: Fanucchi, Laura
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.